Literature DB >> 6408086

The oxidation of 2-aminofluorene by prostaglandin endoperoxide synthetase. Comparison with other peroxidases.

J A Boyd, D J Harvan, T E Eling.   

Abstract

We have examined the prostaglandin endoperoxide synthetase-dependent metabolism of the arylamine carcinogen 2-aminofluorene (2-AF). Ram seminal vesicle microsomes fortified with arachidonic acid metabolize 2-AF to products covalently bound to microsomal macromolecules, water-soluble metabolites, and two organic extractable metabolites. The organic extractable metabolites were identified by co-chromatography, uv-visible spectrophotometry, and mass spectrometry as 2-nitrofluorene and 2,2'-azobisfluorene (azofluorene). Hydrogen peroxide also supports 2-AF metabolism to the same products, suggesting that the hydroperoxidase activity of prostaglandin endoperoxide synthetase is responsible for the co-oxidation. The highly reactive oxygenated metabolites of 2-AF, N-hydroxy-2-AF, and 2-nitrosofluorene, are metabolized by prostaglandin endoperoxide synthetase to one major product, 2-nitrofluorene. The metabolism of 2-AF, N-hydroxy-2-AF, and 2-nitrosofluorene is extremely rapid, reaching completion in less than 30 s. The horseradish peroxidase/H2O2 system also metabolites 2-AF to 2-nitrofluorene and azofluorene. The chloroperoxidase/H2O2 system, however, yields primarily 2-nitrosofluorene from 2-AF. These results suggest that 2-AF is oxidized to an electrophilic intermediate(s) by prostaglandin endoperoxide synthetase, which either binds covalently to tissue macromolecules or is further rapidly oxidized to 2-nitrofluorene and azofluorene. Furthermore, this reaction probably proceeds through a free radical mechanism similar to that of horseradish peroxidase.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6408086

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Dose-dependent reduction of 3,2'-dimethyl-4-aminobiphenyl-derived DNA adducts in colon and liver of rats administered celecoxib.

Authors:  Srivani Ravoori; Yi Feng; Jason R Neale; Jeyaprakash Jeyabalan; Cidambi Srinivasan; David W Hein; Ramesh C Gupta
Journal:  Mutat Res       Date:  2007-09-14       Impact factor: 2.433

2.  N-Oxidation of 4-chloroaniline by prostaglandin synthase. Redox cycling of radical intermediate(s).

Authors:  I Golly; P Hlavica
Journal:  Biochem J       Date:  1985-03-15       Impact factor: 3.857

3.  Inactivation of yeast hexokinase by Cibacron Blue 3G-A: spectral, kinetic and structural investigations.

Authors:  R N Puri; R Roskoski
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

4.  Prostaglandin-H synthase mediated metabolism and mutagenic activation of 2-amino-3-methylimidazo [4,5-f] quinoline (IQ).

Authors:  E Wolz; D Wild; G H Degen
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

5.  The role of lipid peroxidation in the N-oxidation of 4-chloroaniline.

Authors:  I Golly; P Hlavica; J Wolf
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

6.  Modulation of genotoxic and cytotoxic effects of aromatic amines in monolayers of rat hepatocytes.

Authors:  J A Holme; E J Søderlund
Journal:  Cell Biol Toxicol       Date:  1984-10       Impact factor: 6.691

7.  Physiological aspects of free-radical reactions.

Authors:  I Yamazaki; M Tamura; R Nakajima; M Nakamura
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

8.  Role of radical cations in aromatic hydrocarbon carcinogenesis.

Authors:  E Cavalieri; E Rogan
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

9.  Cytosolic activation of aromatic and heterocyclic amines. Inhibition by dicoumarol and enhancement in viral hepatitis B.

Authors:  S De Flora; C Bennicelli; F D'Agostini; A Izzotti; A Camoirano
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

10.  Metabolism of aromatic amines by prostaglandin H synthase.

Authors:  J A Boyd; T E Eling
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.